TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Tilray Brands, Inc.
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$3.03−0.01 (-0.33%)
Close on Oct 19, 2026
- Market cap
- $404.02M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
10.3%
14M of 136M shares
Institutional holders
235
50 new, 20 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
3 buys · 1 sales
Net sold $163.65K
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TLRY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Toroso Investments, LLC | 2,498,656 | 1.83% | $11.22M | −65,033 | 0.02% |
| Susquehanna International Group, Llp | 1,021,777 | 0.75% | $4.59M | +479,545 | 0.00% |
| Morgan Stanley | 995,145 | 0.73% | $4.47M | +354,120 | 0.00% |
| Citadel Advisors LLC | 868,147 | 0.64% | $3.90M | +854,239 | 0.00% |
| Point72 Asset Management, L.P. | 648,506 | 0.48% | $2.91M | New | 0.00% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 646,762 | 0.47% | $2.90M | +159,942 | 0.00% |
| Aqr Capital Management LLC | 512,599 | 0.38% | $2.30M | +65,011 | 0.00% |
| BlackRock, Inc. | 461,656 | 0.34% | $2.07M | +38,758 | 0.00% |
| UBS Group AG | 454,184 | 0.33% | $2.04M | −198,817 | 0.00% |
| Lazard Asset Management LLC | 394,715 | 0.29% | $1.77M | New | 0.00% |
| State Street Corp | 384,123 | 0.28% | $1.72M | +136,123 | 0.00% |
| Vanguard Portfolio Management LLC | 348,679 | 0.26% | $1.57M | −249 | 0.00% |
| Stifel Financial Corp | 290,864 | 0.21% | $1.31M | New | 0.00% |
| XTX Topco Ltd | 245,120 | 0.18% | $1.10M | New | 0.01% |
| Swiss National Bank | 233,803 | 0.17% | $1.05M | +3,300 | 0.00% |
| Goldman Sachs Group Inc | 208,274 | 0.15% | $935.15K | +49,342 | 0.00% |
| UBS Asset Management Americas Inc | 208,229 | 0.15% | $934.95K | +11,894 | 0.00% |
| Headlands Technologies LLC | 160,665 | 0.12% | $721.39K | −14,395 | 0.08% |
| D. E. Shaw & Co., Inc. | 148,383 | 0.11% | $666.36K | −89,388 | 0.00% |
| Two Sigma Investments, LP | 135,870 | 0.10% | $610.06K | −48,973 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 235 | 14M | 10.3% | 50 / 59 | 54 / 20 | 5M | 1M |
| Q1 2026 | 209 | 10M | 7.6% | 39 / 53 | 43 / 37 | 3M | 3M |
| Q4 2025 | 214 | 11M | 8.1% | 212 / 0 | 0 / 0 | 11M | 0M |
| Q3 2025 | 2 | 0M | 0.0% | 2 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q4 2024 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TLRY | Value | % of fund | As of |
|---|---|---|---|---|---|
| Amplify Alternative Harvest ETF | 2,475,946 | 1.82% | $11.12M | 10.03% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 347,389 | 0.26% | $1.91M | 0.01% | May 31, 2026 |
| iShares U.S. Small-Cap Equity Factor ETF | 86,758 | 0.06% | $393.88K | 0.01% | Jul 31, 2026 |
| Dimensional International Small Cap ETF | 79,064 | 0.06% | $254.71K | 0.01% | Jul 31, 2026 |
| AdvisorShares Pure Cannabis ETF | 76,263 | 0.06% | $342.42K | 1.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 69,489 | 0.05% | $382.88K | 0.00% | May 31, 2026 |
| Dimensional International Core Equity Market ETF | 68,858 | 0.05% | $221.83K | 0.00% | Jul 31, 2026 |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | 59,862 | 0.04% | $189.74K | 0.03% | Jun 30, 2026 |
| Fidelity MSCI Health Care Index ETF | 57,332 | 0.04% | $260.29K | 0.01% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | 46,666 | 0.03% | $147.91K | 0.00% | Jun 30, 2026 |
| The Canadian Small Company Series | 37,900 | 0.03% | $122.27K | 0.01% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index ETF | 34,558 | 0.03% | $190.41K | 0.00% | May 31, 2026 |
| World ex U.S. Core Equity Portfolio | 34,437 | 0.03% | $156.34K | 0.00% | Jul 31, 2026 |
| Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | 33,028 | 0.02% | $149.95K | 0.04% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF | 30,827 | 0.02% | $99.31K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Irwin D. Simon | President and CEO, Director | 1,309,031 | 0.96% | Aug 27, 2026 |
| Mitchell Gendel | Global General Counsel | 148,644 | 0.11% | Aug 27, 2026 |
| Denise M. Faltischek | Chief Strategy Officer | 199,489 | 0.15% | Aug 27, 2026 |
| Carl A. Merton | Chief Financial Officer | 241,556 | 0.18% | Aug 27, 2026 |
| Johann Michael Herhalt | Director | 195,561 | 0.14% | Jul 30, 2026 |
| Thomas P. Looney | Director | 397,520 | 0.29% | Jul 30, 2026 |
| Renah Persofsky | Director | 155,357 | 0.11% | Jul 30, 2026 |
| Steven Michael Cohen | Director | 55,542 | 0.04% | Jul 30, 2026 |
| David F. Clanachan | Director | 192,511 | 0.14% | Jul 30, 2026 |
| David G. Hopkinson | Director | 43,104 | 0.03% | Jul 30, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Carl A. Merton Chief Financial Officer | Aug 26, 2026 | Tax withholding | −61,090 | $4.88 | $298.12K | 215,556 |
| Carl A. Merton Chief Financial Officer | Aug 26, 2026 | Tax withholding | −31,559 | $4.88 | $154.01K | 165,574 |
| Carl A. Merton Chief Financial Officer | Aug 26, 2026 | Option exercise | +111,072 | – | – | 276,646 |
| Carl A. Merton Chief Financial Officer | Aug 26, 2026 | Option exercise | +57,380 | – | – | 197,133 |
| Denise M. Faltischek Chief Strategy Officer | Aug 26, 2026 | Option exercise | +58,204 | – | – | 199,489 |
| Denise M. Faltischek Chief Strategy Officer | Aug 26, 2026 | Tax withholding | −30,849 | $4.88 | $150.54K | 168,640 |
| Denise M. Faltischek Chief Strategy Officer | Aug 26, 2026 | Option exercise | +120,017 | – | – | 288,657 |
| Denise M. Faltischek Chief Strategy Officer | Aug 26, 2026 | Tax withholding | −63,610 | $4.88 | $310.42K | 225,047 |
| Mitchell Gendel Global General Counsel | Aug 26, 2026 | Tax withholding | −26,795 | $4.88 | $130.76K | 148,644 |
| Mitchell Gendel Global General Counsel | Aug 26, 2026 | Option exercise | +109,748 | – | – | 258,392 |
| Mitchell Gendel Global General Counsel | Aug 26, 2026 | Tax withholding | −58,167 | $4.88 | $283.85K | 200,225 |
| Mitchell Gendel Global General Counsel | Aug 26, 2026 | Option exercise | +50,556 | – | – | 175,439 |
| Irwin D. Simon President and CEO, Director | Aug 26, 2026 | Tax withholding | −425,889 | $4.88 | $2.08M | 1,309,031 |
| Irwin D. Simon President and CEO, Director | Aug 26, 2026 | Option exercise | +803,563 | – | – | 1,734,920 |
| Irwin D. Simon President and CEO, Director | Aug 26, 2026 | Tax withholding | −216,561 | $4.88 | $1.06M | 931,357 |
| Irwin D. Simon President and CEO, Director | Aug 26, 2026 | Option exercise | +408,605 | – | – | 1,147,918 |
| Mitchell Gendel Global General Counsel | Aug 6, 2026 | Buy | +2,500 | $4.43 | $11.08K | 124,883 |
| Carl A. Merton Chief Financial Officer | Aug 4, 2026 | Buy | +10,000 | $4.62 | $46.20K | 139,753 |
| Denise M. Faltischek Chief Strategy Officer | Aug 3, 2026 | Buy | +2,500 | $4.78 | $11.95K | 141,285 |
| Mitchell Gendel Global General Counsel | Jul 30, 2026 | Option exercise | +24,379 | – | – | 135,304 |
| Mitchell Gendel Global General Counsel | Jul 30, 2026 | Tax withholding | −12,921 | $4.20 | $54.27K | 122,383 |
| Irwin D. Simon President and CEO, Director | Jul 30, 2026 | Option exercise | +117,647 | – | – | 801,666 |
| Irwin D. Simon President and CEO, Director | Jul 30, 2026 | Tax withholding | −62,353 | $4.20 | $261.88K | 739,313 |
| Denise M. Faltischek Chief Strategy Officer | Jul 30, 2026 | Option exercise | +26,120 | – | – | 152,629 |
| Denise M. Faltischek Chief Strategy Officer | Jul 30, 2026 | Tax withholding | −13,844 | $4.20 | $58.14K | 138,785 |
| Carl A. Merton Chief Financial Officer | Jul 30, 2026 | Tax withholding | −9,161 | $4.20 | $38.48K | 129,753 |
| Carl A. Merton Chief Financial Officer | Jul 30, 2026 | Option exercise | +16,656 | – | – | 138,914 |
| Mitchell Gendel Global General Counsel | Jul 29, 2026 | Tax withholding | −46,344 | $3.99 | $184.91K | 110,925 |
| Mitchell Gendel Global General Counsel | Jul 29, 2026 | Option exercise | +87,440 | – | – | 157,269 |
| Irwin D. Simon President and CEO, Director | Jul 29, 2026 | Tax withholding | −227,078 | $3.99 | $906.04K | 684,019 |
| Irwin D. Simon President and CEO, Director | Jul 29, 2026 | Option exercise | +428,448 | – | – | 911,097 |
| Denise M. Faltischek Chief Strategy Officer | Jul 29, 2026 | Tax withholding | −49,654 | $3.99 | $198.12K | 126,509 |
| Denise M. Faltischek Chief Strategy Officer | Jul 29, 2026 | Option exercise | +93,685 | – | – | 176,163 |
| Carl A. Merton Chief Financial Officer | Jul 29, 2026 | Option exercise | +60,417 | – | – | 152,467 |
| Carl A. Merton Chief Financial Officer | Jul 29, 2026 | Tax withholding | −30,209 | $3.99 | $120.53K | 122,258 |
| Renah Persofsky Director | Jul 29, 2026 | Tax withholding | −21,552 | $3.99 | $85.99K | 155,357 |
| Renah Persofsky Director | Jul 29, 2026 | Option exercise | +43,104 | – | – | 176,909 |
| Thomas P. Looney Director | Jul 29, 2026 | Option exercise | +43,104 | – | – | 397,520 |
| Johann Michael Herhalt Director | Jul 29, 2026 | Tax withholding | −21,552 | $3.99 | $85.99K | 195,561 |
| Johann Michael Herhalt Director | Jul 29, 2026 | Option exercise | +43,104 | – | – | 217,113 |
| David G. Hopkinson Director | Jul 29, 2026 | Option exercise | +43,104 | – | – | 43,104 |
| David F. Clanachan Director | Jul 29, 2026 | Tax withholding | −21,552 | $3.99 | $85.99K | 192,511 |
| David F. Clanachan Director | Jul 29, 2026 | Option exercise | +43,104 | – | – | 214,063 |
| Steven Michael Cohen Director | Jul 29, 2026 | Option exercise | +43,104 | – | – | 55,542 |
| David G. Hopkinson Director | Apr 21, 2026 | Sale | −33,556 | $6.94 | $232.88K | 0 |
| Steven Michael Cohen Director | Jan 7, 2026 | Option exercise | +12,438 | $8.99 | $111.82K | 12,438 |
| Mitchell Gendel Global General Counsel | Jul 31, 2025 | Buy | +6,000 | $0.58 | $3.48K | 698,287 |
| Mitchell Gendel Global General Counsel | Jul 31, 2025 | Tax withholding | −49,782 | $0.58 | $28.87K | 692,287 |
| Mitchell Gendel Global General Counsel | Jul 31, 2025 | Option exercise | +93,928 | $0.58 | $54.48K | 742,069 |
| Carl A. Merton Chief Financial Officer | Jul 31, 2025 | Tax withholding | −49,782 | $0.58 | $28.87K | 920,497 |
| Carl A. Merton Chief Financial Officer | Jul 31, 2025 | Option exercise | +93,928 | $0.58 | $54.48K | 970,279 |
| Irwin D. Simon President and CEO | Jul 31, 2025 | Option exercise | +706,216 | $0.58 | $409.61K | 5,200,788 |
| Irwin D. Simon President and CEO | Jul 31, 2025 | Tax withholding | −374,295 | $0.58 | $217.09K | 4,826,493 |
| Denise M. Faltischek Chief Strategy Officer | Jul 31, 2025 | Tax withholding | −49,782 | $0.58 | $28.87K | 824,782 |
| Denise M. Faltischek Chief Strategy Officer | Jul 31, 2025 | Option exercise | +93,928 | $0.58 | $54.48K | 874,564 |
| Denise M. Faltischek Chief Strategy Officer | Jul 30, 2025 | Option exercise | +261,194 | $0.61 | $159.33K | 919,069 |
| Denise M. Faltischek Chief Strategy Officer | Jul 30, 2025 | Tax withholding | −138,433 | $0.61 | $84.44K | 780,636 |
| Irwin D. Simon President and CEO | Jul 30, 2025 | Tax withholding | −623,528 | $0.61 | $380.35K | 4,494,572 |
| Irwin D. Simon President and CEO | Jul 30, 2025 | Option exercise | +1,176,467 | $0.61 | $717.64K | 5,118,100 |
| Johann Michael Herhalt Director | Jul 30, 2025 | Tax withholding | −65,921 | $0.61 | $40.21K | 174,009 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| David G. Hopkinson Director | Apr 21, 2026 | 33,556 | $232.87K | Apr 21, 2026 | Restricted Stock |